Stable isotope tracer dilution for quantifying very low-density lipoprotein-triacylglycerol kinetics in man

Labros S. Sidossis, Faidon Magkos, Bettina Mittendorfer, Robert R. Wolfe

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background & aim: A number of approaches have been employed in the past to measure very low-density lipoprotein (VLDL) triacylglycerol (TG) kinetics in humans in vivo, varying in the selection of tracer and mode of administration. All, however, make use of labeled TG precursors and more or less complicated mathematical models to derive the kinetic parameters of interest. The aim of the present study was to develop a conceptually straightforward method, based on the traditional tracer infusion technique, for quantifying VLDL-TG production rates in man using stable isotopes. Method: Our approach involves ingestion of [U-13 C3]glycerol to endogenously label the glycerol in VLDL-TG, plasmapheresis, isolation of the newly 13C-labeled VLDL from plasma, and administration within the next 2-3 days via a primed constant autologous reinfusion. This procedure produces enough tracer for a priming dose plus 2-3 h of infusion. In the physiological conditions examined (basal and hyperglycemic states, fat- and carbohydrate-rich diets), with almost 3-fold ranging VLDL-TG pool sizes, a steady state in plasma VLDL-TG glycerol tracer-to-tracee ratio was readily achieved within 2 h. Consequently, calculations are made according to the isotope dilution principle, thus avoiding assumptions implicit in more complicated models. Conclusion: The stable isotope VLDL-TG tracer dilution method offers an alternative and reliable tool for the determination of endogenous VLDL-TG kinetics in man under a variety of metabolic states.

Original languageEnglish (US)
Pages (from-to)457-466
Number of pages10
JournalClinical Nutrition
Volume23
Issue number4
DOIs
StatePublished - Aug 2004

Fingerprint

VLDL Lipoproteins
Isotopes
Triglycerides
Glycerol
Plasmapheresis
Theoretical Models
Eating
Fats
Carbohydrates
Diet

Keywords

  • Lipoprotein
  • Liver
  • Methods
  • Splanchnic metabolism
  • Stable isotopes
  • Tracer kinetics
  • Triglyceride

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Endocrinology, Diabetes and Metabolism
  • Gastroenterology
  • Health Professions(all)
  • Medicine (miscellaneous)

Cite this

Stable isotope tracer dilution for quantifying very low-density lipoprotein-triacylglycerol kinetics in man. / Sidossis, Labros S.; Magkos, Faidon; Mittendorfer, Bettina; Wolfe, Robert R.

In: Clinical Nutrition, Vol. 23, No. 4, 08.2004, p. 457-466.

Research output: Contribution to journalArticle

Sidossis, Labros S. ; Magkos, Faidon ; Mittendorfer, Bettina ; Wolfe, Robert R. / Stable isotope tracer dilution for quantifying very low-density lipoprotein-triacylglycerol kinetics in man. In: Clinical Nutrition. 2004 ; Vol. 23, No. 4. pp. 457-466.
@article{4286a63e40ba4d8cb41d382e3413d19a,
title = "Stable isotope tracer dilution for quantifying very low-density lipoprotein-triacylglycerol kinetics in man",
abstract = "Background & aim: A number of approaches have been employed in the past to measure very low-density lipoprotein (VLDL) triacylglycerol (TG) kinetics in humans in vivo, varying in the selection of tracer and mode of administration. All, however, make use of labeled TG precursors and more or less complicated mathematical models to derive the kinetic parameters of interest. The aim of the present study was to develop a conceptually straightforward method, based on the traditional tracer infusion technique, for quantifying VLDL-TG production rates in man using stable isotopes. Method: Our approach involves ingestion of [U-13 C3]glycerol to endogenously label the glycerol in VLDL-TG, plasmapheresis, isolation of the newly 13C-labeled VLDL from plasma, and administration within the next 2-3 days via a primed constant autologous reinfusion. This procedure produces enough tracer for a priming dose plus 2-3 h of infusion. In the physiological conditions examined (basal and hyperglycemic states, fat- and carbohydrate-rich diets), with almost 3-fold ranging VLDL-TG pool sizes, a steady state in plasma VLDL-TG glycerol tracer-to-tracee ratio was readily achieved within 2 h. Consequently, calculations are made according to the isotope dilution principle, thus avoiding assumptions implicit in more complicated models. Conclusion: The stable isotope VLDL-TG tracer dilution method offers an alternative and reliable tool for the determination of endogenous VLDL-TG kinetics in man under a variety of metabolic states.",
keywords = "Lipoprotein, Liver, Methods, Splanchnic metabolism, Stable isotopes, Tracer kinetics, Triglyceride",
author = "Sidossis, {Labros S.} and Faidon Magkos and Bettina Mittendorfer and Wolfe, {Robert R.}",
year = "2004",
month = "8",
doi = "10.1016/j.clnu.2003.11.006",
language = "English (US)",
volume = "23",
pages = "457--466",
journal = "Clinical Nutrition",
issn = "0261-5614",
publisher = "Churchill Livingstone",
number = "4",

}

TY - JOUR

T1 - Stable isotope tracer dilution for quantifying very low-density lipoprotein-triacylglycerol kinetics in man

AU - Sidossis, Labros S.

AU - Magkos, Faidon

AU - Mittendorfer, Bettina

AU - Wolfe, Robert R.

PY - 2004/8

Y1 - 2004/8

N2 - Background & aim: A number of approaches have been employed in the past to measure very low-density lipoprotein (VLDL) triacylglycerol (TG) kinetics in humans in vivo, varying in the selection of tracer and mode of administration. All, however, make use of labeled TG precursors and more or less complicated mathematical models to derive the kinetic parameters of interest. The aim of the present study was to develop a conceptually straightforward method, based on the traditional tracer infusion technique, for quantifying VLDL-TG production rates in man using stable isotopes. Method: Our approach involves ingestion of [U-13 C3]glycerol to endogenously label the glycerol in VLDL-TG, plasmapheresis, isolation of the newly 13C-labeled VLDL from plasma, and administration within the next 2-3 days via a primed constant autologous reinfusion. This procedure produces enough tracer for a priming dose plus 2-3 h of infusion. In the physiological conditions examined (basal and hyperglycemic states, fat- and carbohydrate-rich diets), with almost 3-fold ranging VLDL-TG pool sizes, a steady state in plasma VLDL-TG glycerol tracer-to-tracee ratio was readily achieved within 2 h. Consequently, calculations are made according to the isotope dilution principle, thus avoiding assumptions implicit in more complicated models. Conclusion: The stable isotope VLDL-TG tracer dilution method offers an alternative and reliable tool for the determination of endogenous VLDL-TG kinetics in man under a variety of metabolic states.

AB - Background & aim: A number of approaches have been employed in the past to measure very low-density lipoprotein (VLDL) triacylglycerol (TG) kinetics in humans in vivo, varying in the selection of tracer and mode of administration. All, however, make use of labeled TG precursors and more or less complicated mathematical models to derive the kinetic parameters of interest. The aim of the present study was to develop a conceptually straightforward method, based on the traditional tracer infusion technique, for quantifying VLDL-TG production rates in man using stable isotopes. Method: Our approach involves ingestion of [U-13 C3]glycerol to endogenously label the glycerol in VLDL-TG, plasmapheresis, isolation of the newly 13C-labeled VLDL from plasma, and administration within the next 2-3 days via a primed constant autologous reinfusion. This procedure produces enough tracer for a priming dose plus 2-3 h of infusion. In the physiological conditions examined (basal and hyperglycemic states, fat- and carbohydrate-rich diets), with almost 3-fold ranging VLDL-TG pool sizes, a steady state in plasma VLDL-TG glycerol tracer-to-tracee ratio was readily achieved within 2 h. Consequently, calculations are made according to the isotope dilution principle, thus avoiding assumptions implicit in more complicated models. Conclusion: The stable isotope VLDL-TG tracer dilution method offers an alternative and reliable tool for the determination of endogenous VLDL-TG kinetics in man under a variety of metabolic states.

KW - Lipoprotein

KW - Liver

KW - Methods

KW - Splanchnic metabolism

KW - Stable isotopes

KW - Tracer kinetics

KW - Triglyceride

UR - http://www.scopus.com/inward/record.url?scp=4243132763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4243132763&partnerID=8YFLogxK

U2 - 10.1016/j.clnu.2003.11.006

DO - 10.1016/j.clnu.2003.11.006

M3 - Article

VL - 23

SP - 457

EP - 466

JO - Clinical Nutrition

JF - Clinical Nutrition

SN - 0261-5614

IS - 4

ER -